Spanning from the West to East: An Updated Review on Endovascular Treatment of Intracranial Atherosclerotic Disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28400985)

Published in Aging Dis on April 01, 2017

Authors

Mohammed Hussain1, Neil Datta1, Zhe Cheng2, David Dornbos3, Asif Bashir4, Ibrahim Sultan5, Tapan Mehta1, Faris Shweikeh6, Paul Mazaris1, Nora Lee1, Amre Nouh1, Xiaokun Geng7, Yuchuan Ding8

Author Affiliations

1: 1Department of Neurology, University of Connecticut, Farmington, CT 06030, USA.
2: 2Department of Neurology, Luhe Hospital, Capital Medical University, Beijing 101149, China.
3: 3Department of Neurological Surgery, The Ohio State University Wexner Medical Center, OH 43210, USA.
4: 4Department of Neurosurgery, Seton Hall University, South Orange, NJ 07079, USA.
5: 5Department of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
6: 6Department of Surgery, University of Arizona, Tucson, AZ 85724, USA.
7: 2Department of Neurology, Luhe Hospital, Capital Medical University, Beijing 101149, China; 7Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI 48236, USA.
8: 7Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI 48236, USA.

Articles cited by this

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 7.48

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57

Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke (1995) 4.54

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21

Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke (2004) 3.90

The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology (2008) 3.77

US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke (2007) 3.17

Global burden of intracranial atherosclerosis. Int J Stroke (2006) 2.98

A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke (2009) 2.80

A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke (2007) 2.70

Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation (2001) 2.56

Race and sex differences in the distribution of cerebral atherosclerosis. Stroke (1996) 2.35

The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10

Joint study of extracranial arterial occlusion. II. Arteriography, techniques, sites, and complications. JAMA (1968) 1.93

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke (2012) 1.91

Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke (2006) 1.83

Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg (1993) 1.81

Clinical events following neuroangiography: a prospective study. Stroke (1988) 1.70

Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke (2011) 1.62

Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery (2013) 1.58

Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg (1999) 1.46

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol (2013) 1.23

Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am (2007) 1.20

Racial differences in ischemic cerebrovascular disease: clinical and magnetic resonance angiographic correlations of white and Asian patients. J Stroke Cerebrovasc Dis (2007) 1.09

Racial differences in the distribution of posterior circulation occlusive disease. Stroke (1985) 1.07

Intracranial atherosclerosis. Lancet (2013) 1.02

Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology (2005) 1.01

Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev (2006) 1.01

Intracranial atherosclerosis: current understanding and perspectives. J Stroke (2014) 1.00

Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery (2002) 0.97

How effective is endovascular intracranial revascularization in stroke prevention? Results from Borgess Medical Center Intracranial Revascularization Registry. AJNR Am J Neuroradiol (2011) 0.93

Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis. Neurosurgery (2013) 0.92

Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS. J Neurointerv Surg (2014) 0.90

Stroke recurrence rates among patients with symptomatic intracranial vertebrobasilar stenoses: systematic review and meta-analysis. J Neurointerv Surg (2014) 0.90

Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery (2009) 0.90

Treatment of atherosclerotic intracranial arterial stenosis. Stroke (2009) 0.89

Mechanism of procedural failure related to wingspan. Neurointervention (2012) 0.87

Angioplasty and stenting of intracranial atherosclerosis with the Wingspan system: 1-year clinical and radiological outcome in a single Asian center. J Neurointerv Surg (2013) 0.86

Standard of practice: endovascular treatment of intracranial atherosclerosis. J Neurointerv Surg (2012) 0.85

Management of patients with symptomatic intracranial atherosclerosis. Int J Stroke (2006) 0.82

Endovascular therapy for atherosclerotic intracranial arterial stenosis: back to the drawing board. JAMA (2015) 0.81

Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients. BMC Neurol (2015) 0.78

Endovascular management of intracranial atherosclerosis. Neurosurg Clin N Am (2014) 0.76

Endovascular treatment of symptomatic intracranial atherosclerotic disease. Front Neurol (2011) 0.76

Insight into the periprocedural embolic events of internal carotid artery angioplasty. A report of four cases and literature review. Interv Neuroradiol (2011) 0.76